Scott William Drake - 07 May 2021 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Role: Director
Signature: /s/ Scott W. Drake
Issuer symbol: ATRC
Transactions as of: 07 May 2021
Transactions value $: -$2,975,915
Form type: 4
Filing time: 11 May 2021, 08:46:05
Next filing: 16 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRC	Common Stock	Options Exercise	$347K	+38.6K	+94.16%	$8.98^*	79.7K	07 May 2021	Direct
transaction	ATRC	Common Stock	Sale	-$3.01M	-38.6K	-48.5%	$77.90	41K	07 May 2021	Direct	F1
transaction	ATRC	Common Stock	Options Exercise	$41.6K	+4.63K	+11.29%	$8.98^*	45.7K	10 May 2021	Direct
transaction	ATRC	Common Stock	Sale	-$354K	-4.63K	-10.14%	$76.52	41K	10 May 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATRC	Stock Option (Right to Buy)	Options Exercise	$0	-38.6K	-77.28%	$0.00	11.4K	07 May 2021	Common Stock	38.6K	$8.98	Direct	F3
transaction	ATRC	Stock Option (Right to Buy)	Options Exercise	$0	-4.63K	-40.77%	$0.00	6.73K	10 May 2021	Common Stock	4.63K	$8.98	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $77.52 to $79.13 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	This transaction was executed in multiple trades at prices ranging from $76.00 to $76.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3	These options were granted on September 3, 2013. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.